A. Roussel

Higher Frequency of Dipeptidyl Peptidase-4 Inhibitor Intake in Bullous Pemphigoid Patients than in the French General Population

Marthe Plaquevent, F. Tétart, L. Fardet et al. · Journal of Investigative Dermatology · 2018 · 83 citations · Full text

French General Population, Higher Frequency, Bullous Pemphigoid Patients +2

Enzyme-Linked Immunosorbent Assay for the Combination of Bullous Pemphigoid Antigens 1 and 2 in the Diagnosis of Bullous Pemphigoid

A. Roussel, Jacques Bénichou, Zely Arivelo Randriamanantany et al. · Archives of Dermatology · 2011 · 72 citations

Recurrence of drug‐induced reactions in <scp>DRESS</scp> patients

D Picard, Marlène Vellar, Baptiste Janela et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 66 citations

Clinical and immunological features and outcome of anti-p200 pemphigoid

M.-H. Commin, Enno Schmidt, S. Duvert‐Lehembre et al. · British Journal of Dermatology · 2016 · 46 citations

International multicentre observational study to assess the efficacy and safety of a 0·5 mg kg ⁻¹ per day starting dose of oral corticosteroids to treat bullous pemphigoid

V. Hébert, S. Bastos, Kossara Drenovska et al. · British Journal of Dermatology · 2021 · 18 citations · Full text